HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|123|5|298-305

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.123, Iss.5, 2015-05, pp. : 298-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chromophobe Cell Renal Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 3, 1999-02 ,pp. : 172-174

Karger

Access to resources Recommend Favorite

Expression of KIT (CD117) in Renal Cell Carcinoma and Renal Oncocytoma

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 269-275

Karger

Access to resources Recommend Favorite

Chromophobe Renal Cell Carcinoma with Osteosarcoma Differentiation: Case Report and Literature Review

By  

Urologia Internationalis, Vol. 85, Iss. 4, 2010-09 ,pp. : 470-474

Karger

Access to resources Recommend Favorite

Increased Transforming Growth Factor β1 Plasma Level in Patients with Renal Cell Carcinoma:A Tumor-Specific Marker?

By  

Urologia Internationalis, Vol. 60, Iss. 4, 1998-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite

Expression of Renal Cystic Genes in Patients with HNF1B Mutations

By  

Nephron Clin Pract, Vol. 120, Iss. 2, 2012-01 ,pp. : c71-c78

Karger

Access to resources Recommend Favorite